FB2026_03 , released September 17, 2026
Human Disease Model Report: inclusion body myopathy with or without frontotemporal dementia (postulated), SVIP-related
Open Close
General Information
Name
inclusion body myopathy with or without frontotemporal dementia (postulated), SVIP-related
FlyBase ID
FBhh0001315
OMIM
Overview

This report describes an inclusion body myopathy with or without frontotemporal dementia postulated to be caused by the SVIP gene. SVIP (small VCP interacting protein) encodes an inhibitor of the endoplasmic reticulum-associated degradation (ERAD) pathway. The VCP gene is implicated in inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 (see FBhh0000075). There is a single gene in Drosophila orthologous to SVIP, Dmel\Svip; both genes encode small polypeptides, 77-82 amino acids. An amorphic mutation, RNAi-targeting constructs, and regulated expression constructs have been generated for Svip.

The human SVIP gene has not been introduced into flies.

Animals homozygous for an amorphic mutation of Svip show increased rates of pupal lethality, have a reduced adult lifespan, and exhibit a progressive, degenerative phenotype in muscle and motor neurons that is similar to that observed in disease-implicated variants of VCP (TER94 in Drosophila). The diminished lifespan can be fully rescued by muscle-specific expression of UAS-Svip, but not by neuronal expression of UAS-Svip. A variant analogous to one found in a patient has been introduced into the fly gene. Variant(s) implicated in human disease introduced (as analogous mutation in fly gene): S82L in the fly Svip gene (corresponds to S77L in the human SVIP gene); see the 'Disease-Implicated Variants' table below. Although the variant protein can still bind VCP in vitro, it disrupts tubular lysosomes in Drosophila larval muscle in a dominant fashion. Animals carrying either the knockout mutation or the S82L mutation of Svip exhibit resistance to tunicamycin, which is known to exacerbate ER stress.

[updated Mar. 2024 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: inclusion body myopathy with Paget disease of bone and frontotemporal dementia
Symptoms and phenotype

Inclusion body myopathy associated with Paget disease of bone (PDB) and/or frontotemporal dementia (IBMPFD) is characterized by adult-onset proximal and distal muscle weakness (clinically resembling a limb-girdle muscular dystrophy syndrome), early-onset PDB, and premature frontotemporal dementia (FTD). Muscle weakness progresses to involve other limb and respiratory muscles. Cardiac failure and cardiomyopathy have been observed in later stages. PDB involves focal areas of increased bone turnover that typically lead to spine and/or hip pain and localized enlargement and deformity of the long bones; pathologic fractures occur on occasion. Early stages of FTD are characterized by dysnomia, dyscalculia, comprehension deficits, paraphasic errors, and relative preservation of memory, and later stages by inability to speak, auditory comprehension deficits for even one-step commands, alexia, and agraphia. Mean age at diagnosis for muscle disease and PDB is 42 years; for FTD, 55 years. [from GeneReviews, Inclusion Body Myopathy with Paget Disease of Bone and/or Frontotemporal Dementia, pubmed:20301649 2016.06.03]

IBMPFD is a autosomal dominant disorder linked to multiple genes, characterized by incomplete penetrance of 3 main features: disabling muscle weakness (in 90%), osteolytic bone lesions consistent with Paget disease (in 51%), and frontotemporal dementia (in 32%). Muscle weakness is an isolated symptom in about 30% of patients and the presenting symptom in greater than half of patients, suggesting that IBMPFD may commonly be seen in a neuromuscular clinic without its other syndromic features (review by Weihl et al., 2009, pubmed:19380227). [From MIM:167320, 2016.06.03]

Specific Disease Summary: inclusion body myopathy with or without frontotemporal dementia (postulated), SVIP-related
OMIM report
Human gene(s) implicated
Symptoms and phenotype
Genetics

A patient suffering from frontotemporal dementia was determined to have a missense (S77L) mutation in SVIP (FBrf0247840). Since SVIP encodes a very small polypeptide (77 amino acids in human), deleterious variants are likely to be rare.

Cellular phenotype and pathology
Molecular information

SVIP encodes an inhibitor of the ERAD (endoplasmic reticulum-associated degradation) pathway; this pathway functions to target misfolded proteins in the endoplasmic reticulum to the proteasome for degradation. [Gene Cards, SVIP; 21.02.07]

External links
Disease synonyms
IBMPFD (postulated), SVIP-related
Ortholog Information
Human gene(s) in FlyBase
    Human gene (HGNC)
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    One to one: 1 human gene to 1 Drosophila gene.

    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (1)
      Molecular function (GO)
        Gene Groups / Pathways
          Comments on ortholog(s)

          Moderate-scoring ortholog of human SVIP (1 Drosophila to 1 human). Dmel\CG32039 shares 33% identity and 60% similarity with the human gene. Both proteins are small, 79-82 amino acids.

          Orthologs and Alignments from DRSC
          DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
          Other Genes Used: Viral, Bacterial, Synthetic (0)
            Summary of Physical Interactions (1 groups)
            protein-protein
            Interacting group
            Assay
            References
            pull down, molecular weight estimation by staining, anti tag western blot
            Alleles Reported to Model Human Disease (Disease Ontology) (3 alleles)
            Models Based on Experimental Evidence ( 3 )
            Allele
            Disease
            Evidence
            References
            Modifiers Based on Experimental Evidence ( 0 )
            Allele
            Disease
            Interaction
            References
            Alleles Representing Disease-Implicated Variants
            Genetic Tools, Stocks and Reagents
            Sources of Stocks
            Contact lab of origin for a reagent not available from a public stock center.
            Bloomington Stock Center Disease Page
            Related mammalian, viral, bacterial, or synthetic transgenes
            Allele
            Transgene
            Publicly Available Stocks
            Selected Drosophila transgenes
            Allele
            Transgene
            Publicly Available Stocks
            RNAi constructs available
            Allele
            Transgene
            Publicly Available Stocks
            Selected Drosophila classical alleles
            Allele
            Allele class
            Mutagen
            Publicly Available Stocks
            amorphic allele - molecular evidence
            CRISPR/Cas9
            References (4)